Showing results (101-110 of 254) with videos related to

Sort By:
Pageof 26
Proceedings (Baylor University. Medical Center)|April 22, 2020
Diffuse dermal angiomatosis of the breastNicholas Nguyen, Annika S Silfvast-Kaiser, Jillian Frieder, et al.
Archives of Dermatology|December 17, 2003
Treatment of psoriasis with alefacept: correlation of clinical improvement with reductions of memory T-cell countsKenneth B Gordon, Akshay K Vaishnaw, John O'Gorman, et al.
Seminars in Cutaneous Medicine and Surgery|April 4, 2018
Treating to Target-A Realistic Goal in Psoriasis?Kenneth B Gordon, April W Armstrong, M Alan Menter, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 19, 2018
Epidermal Fluence Threshold Determination by Real-Time Melanin MeasurementsAmanda Abramson Lloyd, Michael S Graves, Edward V Ross
Journal of Drugs in Dermatology : JDD|June 3, 2020
Importance of Complete Skin Clearance in Psoriasis as a Treatment Goal: Implications for Patient-Reported OutcomesAndrew Blauvelt, Jashin J Wu, April Armstrong, et al.
Journal of Drugs in Dermatology : JDD|October 15, 2016
Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind StudyAlice Gottlieb, Alan Menter, April Armstrong, et al.
Journal of the American Academy of Dermatology|April 19, 2014
The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous diseaseAntoinette Day, Amanda K Abramson, Mahir Patel, et al.
Dermatology and Therapy|August 21, 2020
A Real-World Evaluation of the Long-Term Safety and Efficacy of Infliximab in the Treatment Moderate-to-Severe PsoriasisEmily K Haque, Aaminah Azhar, John Corbett, et al.
Dermatology and Therapy|April 4, 2020
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available EvidenceJashin J Wu, Joseph F Merola, Steven R Feldman, et al.
Pageof 26